GSK-2793660 是一种具有口服活性并且不可逆的组织蛋白酶 C (Cathepsin C；CTSC) 抑制剂。GSK-2793660 是一种生物活性肽，可用于支气管扩张的研究。

GSK-2793660 is an orally active and irreversible inhibitor of Cathepsin C (CTSC). GSK-2793660 is a bioactive dipeptide that can be used for the research of bronchiectasis [1] [2].

GSK-2793660 is a cathepsin C (also known as dipeptidyl peptidase I enzyme) inhibitor in clinical trials for the treatment of cystic fibrosis, non-cystic fibrosis bronchiectasis, anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and bronchiectasis [1].

1613458-70-0

C20H27N3O3

357.45

GSK-2793660

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years